Stem cell transplantation for autoimmune diseases: What can we learn from experimental models?

References

• Ikehara S, Good RA, Nakamura T, et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985; 82(8)2483–2487
   PubMed Web of Science ®Google Scholar
• Ikehara S, Ohtsuki H, Good RA, et al. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci USA 1985; 82(22)7743–7747
   PubMed Web of Science ®Google Scholar
• Oyaizu N, Yasumizu R, Miyama-Inaba M, et al. (NZW × BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J Exp Med 1988; 167(6)2017–2022
   PubMedGoogle Scholar
• Nakagawa T, Nagata N, Hosaka N, et al. Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells). Arthritis Rheum 1993; 36(2)263–268
   PubMed Web of Science ®Google Scholar
• Nishimura M, Toki J, Sugiura K, et al. Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder. J Exp Med 1994; 179(3)1053–1058
   PubMedGoogle Scholar
• Than S, Ishida H, Inaba M, et al. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J Exp 1992; 176(4)1233–1238
   PubMedGoogle Scholar
• Baldwin JL, Storb R, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977; 20(5)1043–1048
   PubMedGoogle Scholar
• Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1986; 1(2)237–239
   PubMedGoogle Scholar
• Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993; 20(1)137–140
   PubMedGoogle Scholar
• Eedy DJ, Burrows D, Bridges JM, Jones FG. Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 1990; 300(6729)908
   PubMedGoogle Scholar
• Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992; 9(1)31–33
   PubMedGoogle Scholar
• Marmont AM. Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases?. Stem Cells 1994; 12(1)125–135
   PubMed Web of Science ®Google Scholar
• Sullivan KM, Furst DE. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. J Rheumatol Suppl 1997; 48: 1–4
   PubMedGoogle Scholar
• Nelson JL, Torrez R, Louie FM, et al. Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. J Rheumatol Suppl 1997; 48: 23–29
   PubMedGoogle Scholar
• Snowden JA, Kearney P, Kearney A, et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998; 41(3)453–459
   PubMed Web of Science ®Google Scholar
• Marmont AM. Stem cell transplantation for severe autoimmune diseases: Progress and problems. Haematologica 1998; 83(8)733–743
   PubMedGoogle Scholar
• Burt RK. BMT for severe autoimmune diseases: An idea whose time has come. Oncology (Williston Park) 1997; 11(7)1001–1014, 1017, Discussion 1018-1024
   PubMedGoogle Scholar
• Tyndall A, Black C, Finke J, et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 1997; 349(9047)254
   PubMed Web of Science ®Google Scholar
• Traynor AE, Schroeder J, Rosa RM, et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: A phase I study. Lancet 2000; 356(9231)701–707
   PubMed Web of Science ®Google Scholar
• Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88(9)3621–3625
   PubMed Web of Science ®Google Scholar
• Denman AM, Russell AS, Denman EJ. Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol 1969; 5(6)567–595
   PubMed Web of Science ®Google Scholar
• Morton JI, Siegel BV. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci USA 1974; 71(6)2162–2165
   PubMed Web of Science ®Google Scholar
• Morton JL, Siegel BV. Transplantation of autoimmune potential. IV. Reversal of the NZB autoimmune syndrome by bone marrow transplantation. Transplantation 1979; 27(2)133–134
   PubMedGoogle Scholar
• Serreze DV, Leiter EH, Worthen SM, Shultz LD. NOD marrow stem cells adoptively transfer diabetes to resistant (NOD × NON)F1 mice. Diabetes 1988; 37(2)252–255
   PubMedGoogle Scholar
• Wicker LS, Miller BJ, Chai A, et al. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD × B10) F1 mice with bone marrow cells from NOD mice. J Exp Med 1988; 167(6)1801–1810
   PubMedGoogle Scholar
• LaFace DM, Peck AB. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 1989; 38(7)894–901
   PubMedGoogle Scholar
• Naji A, Silvers WK, Kimura H, et al. Influence of islet and bone marrow transplantation on the diabetes and immunodeficiency of BB rats. Metabolism 1983; 32(7 Suppl 1)62–68
   PubMedGoogle Scholar
• Ikehara S, Kawamura M, Takao F, et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87(21)8341–8344
   PubMed Web of Science ®Google Scholar
• Kawamura M, Hisha H, Li Y, et al. Distinct qualitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro. Stem Cells 1997; 15(1)56–62
   PubMedGoogle Scholar
• van Bekkum DW, Bohre EP, Houben PF, Knaan-Shanzer S. Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 1989; 86(24)10090–10094
   PubMed Web of Science ®Google Scholar
• Karussis DM, Slavin S, Lehmann D, et al. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992; 148(6)1693–1698
   PubMed Web of Science ®Google Scholar
• van Gelder M, Kinwel-Bohre EP, van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993; 11(3)233–241
   PubMed Web of Science ®Google Scholar
• Ikehara S. A novel strategy for allogeneic stem cell transplantation: Perfusion method plus intra-bone marrow injection of stem cells. Exp Hematol 2003; 31(12)1142–1146
   PubMedGoogle Scholar
• Ikehara S, Yasumizu R, Inaba M, et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989; 86(9)3306–3310
   PubMed Web of Science ®Google Scholar
• Doi H, Inaba M, Yamamoto Y, et al. Pluripotent hemopoietic stem cells are c-kit < low. Proc Natl Acad Sci USA 1997; 94(6)2513–2517
   PubMedGoogle Scholar
• Sugiura K, Inaba M, Ogata H, et al. Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc Natl Acad Sci USA 1988; 85(13)4824–4826
   PubMedGoogle Scholar
• Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol 2001; 29(6)661–669
   PubMed Web of Science ®Google Scholar
• Kushida T, Inaba M, Hisha H, et al. Crucial role of donor-derived stromal cells in successful treatment for intractable autoimmune diseases in MRL/lpr mice by BMT via portal vein. Stem Cells 2001; 19(3)226–235
   PubMedGoogle Scholar
• Fan TX, Hisha H, Jin TN, et al. Successful allogeneic bone marrow transplantation (BMT) by injection of bone marrow cells via portal vein: Stromal cells as BMT-facilitating cells. Stem Cells 2001; 19(2)144–150
   PubMedGoogle Scholar
• Hashimoto F, Sugiura K, Inoue K, Ikehara S. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997; 89(1)49–54
   PubMedGoogle Scholar
• Sugiura K, Hisha H, Ishikawa J, et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro. Stem Cells 2001; 19(1)46–58
   PubMedGoogle Scholar
• Kushida T, Inaba M, Hisha H, et al. Intra-bone marrow injection of allogeneic bone marrow cells: A powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 2001; 97(10)3292–3299
   PubMed Web of Science ®Google Scholar
• van Hennik PB, de Koning AE, Ploemacher RE. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: Implications for stem cell frequency assessment. Blood 1999; 94(9)3055–3061
   PubMedGoogle Scholar
• Cashman JD, Eaves CJ. High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. Blood 2000; 96(12)3979–3981
   PubMedGoogle Scholar
• Panoskaltsis-Mortari A, Price A, Hermanson JR, et al. In vivo imaging of graft-versus-host-disease in mice. Blood 2004; 103(9)3590–3598
   PubMedGoogle Scholar
• Zhang Y, Yasumizu R, Sugiura K, et al. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation for the mechanism of tolerance induction by portal vein injection. Eur J Immunol 1994; 24(7)1558–1565
   PubMedGoogle Scholar
• Ichioka N, Inaba M, Kushida T, et al. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells 2002; 20(6)542–551
   PubMed Web of Science ®Google Scholar
• Takada K, Inaba M, Ichioka N, et al. Treatment of senile osteoporosis in SAMP6 mice by intra-bone marrow injection of allogeneic bone marrow cells. Stem Cells 2006; 24(2)399–405
   PubMed Web of Science ®Google Scholar
• Wang J, Kimura T, Asada R, et al. SCID-repopulating cell activity of human cord blood-derived CD34− cells assured by intra-bone marrow injection. Blood 2003; 101(8)2924–2931
   PubMedGoogle Scholar
• Yahata T, Ando K, Sato T, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003; 101(8)2905–2913
   PubMedGoogle Scholar
• Mazurier F, Doedens M, Gan OI, Dick JE. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003; 9(7)959–963
   PubMedGoogle Scholar
• Castello S, Podesta M, Menditto VG, et al. Intra-bone marrow injection of bone marrow and cord blood cells: An alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol 2004; 32(8)782–787
   PubMed Web of Science ®Google Scholar
• Ikehara S. New strategies for BMT, organ transplantation, and regeneration therapy. Hematology 2003; 8(2)77–81
   PubMedGoogle Scholar
• Taira M, Inaba M, Takada K, et al. Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells. Transplantation 2005; 79(6)680–687
   PubMedGoogle Scholar
• Esumi T, Inaba M, Ichioka N, et al. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Transplantation 2003; 76(11)1543–1548
   PubMedGoogle Scholar
• Kushida T, Inaba M, Ikebukuro K, et al. A new method for bone marrow cell harvesting. Stem Cells 2000; 18(6)453–456
   PubMedGoogle Scholar
• Kushida T, Inaba M, Ikebukuro K, et al. Comparison of bone marrow cells harvested from various bones of cynomolgus monkeys at various ages by perfusion or aspiration methods: A preclinical study for human BMT. Stem Cells 2002; 20(2)155–162
   PubMedGoogle Scholar
• Thomas ED, Storb R. Technique for human marrow grafting. Blood 1970; 36(4)507–515
   PubMed Web of Science ®Google Scholar
• Inaba M, Adachi Y, Hisha H, et al. Extensive studies on perfusion method plus intra-bone marrow-bone marrow transplantation using cynomolgus monkeys. Stem Cells 2007; 25(8)2098–2103
   PubMedGoogle Scholar
• Beatty PG, Anasetti C, Hansen JA, et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus. Blood 1993; 81(1)249–253
   PubMedGoogle Scholar
• Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324(10)667–674
   PubMed Web of Science ®Google Scholar
• Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328(9)593–602
   PubMed Web of Science ®Google Scholar
• Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57(2)267–276
   PubMed Web of Science ®Google Scholar
• Block MH. Postnatal hematopoietic tissue. Text-atlas of hematology. Lea and Febiger, Philadelphia 1976; 31–51
   Google Scholar
• Li C, He Y, Feng X, et al. An innovative approach to bone marrow collection and transplantation in a patient with beta-thalassemia major: Marrow collection using a perfusion method followed by intra-bone marrow injection of collected bone marrow cells. Int J Hematol 2007; 85(1)73–77
   PubMed Web of Science ®Google Scholar
• Marmont AM, Merlini G. Monoclonal autoimmunity in hematology. Haematologica 1991; 76(6)449–459
   PubMedGoogle Scholar
• Adachi Y, Oyaizu H, Taketani S, et al. Treatment and transfer of emphysema by a new bone marrow transplantation method from normal mice to Tsk mice and vice versa. Stem Cells 2006; 24(9)2071–2077
   PubMedGoogle Scholar
• Ueda Y, Inaba M, Takada K, et al. Induction of senile osteoporosis in normal mice by intra-bone marrow-bone marrow transplantation from osteoporosis-prone mice. Stem Cells 2007; 25(6)1356–1363
   PubMedGoogle Scholar
• Ikehara S. A new concept of stem cell disorders and their new therapy. J Hematother Stem Cell Res 2003; 12(6)643–653
   PubMedGoogle Scholar
• Ikehara S. Intra-bone marrow-bone marrow transplantation: A new strategy for treatment of stem cell disorders. Ann N Y Acad Sci 2005; 1051: 626–634
   PubMed Web of Science ®Google Scholar
• Nakamura K, Inaba M, Sugiura K, et al. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. Stem Cells 2004; 22(2)125–134
   PubMedGoogle Scholar
• Kuroiwa T, Kakishita E, Hamano T, et al. Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J Clin Invest 2001; 107(11)1365–1373
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99(10)3838–3843
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Adachi Y, Minamino K, et al. A new strategy for treatment of malignant tumor: Intra-bone marrow-bone marrow transplantation plus CD4− donor lymphocyte infusion. Stem Cells 2005; 23(3)365–370
   PubMedGoogle Scholar
• Mukaide H, Adachi Y, Koike-Kiriyama N, et al. Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow-bone marrow transplantation, donor lymphocyte infusion and dendritic cells. Int J Oncol 2007; 30(6)1309–1315
   PubMedGoogle Scholar
• Koike Y, Adachi Y, Suzuki Y, et al. Allogeneic intrabone marrow-bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats. Stem Cells 2007; 25(2)385–391
   PubMedGoogle Scholar